No Detail Found!

Quantification and characterization of Myo-inositol in locally available peanuts and pine nuts in Pakistan

Author(s)
Shagufta Kamal Department of Biochemistry, Govt. College University,Faisalabad,Pakistan
Naheed Akhter Department of Allied Health Professional, Govt. College University,Faisalabad,Pakistan
Nazia Yaqoob Deparment of Chemistry, Govt. College Women University,Faisalabad,Pakistan
Uzma Qaisar School of Biological Sciences, Punjab University,Lahore,Pakistan
Ismat Bibi Deparment of Chemistry, The Islamia University of the Bhawalpur,Bhawalpur,Pakistan
Saira Shahzadi Department of Chemistry, Quaid-e-Azam University,Islamabad,Pakistan
Aqsa Nadeem Department of Chemistry, Quaid-e-Azam University,Islamabad,Pakistan
Muhamamd Azeem Department of Botany, Govt. College University,Faisalabad,Pakistan
Abstract
Inositol is one of nine biologically significant isomers of hexa hydroxy-cyclohexane which plays important role for bone formation and bone mineral density. The study was conducted to quantify and characterize the myo inositol crystals isolated from the pine nuts and peanuts. High-performance liquid chromatography, UV, FTIR and XRD was utilized for the rapid, on-line detection of inositol phosphate (InsP). The absorption peaks at 382.63nm for 0.10mg peanuts and 382.68 for 0.07mg pine nuts by UV-Visible spectroscopy confirmed the presence of myoinositol. Total concentration of myoinositol obtained was 0.23 and 5.31mmol/kg. The X-ray crystallography analysis showed that the unit-cell parameters a = 6.7226 (3) Å, b = 12.1462 (5) Å, c = 18.9942 (8) Å, a= 89.00, ß= 94.98, d= 989.00. The crystal density was reported at 1.6 cm-3 while the crystal volume was recorded at 1504.7(11) Å3. The stretching frequencies of myo-inositol crystals were observed in the region of 3800-3778 cm-1 related to alcohol O-H groups of myo-inositol. It is therefore concluded and recommended that dry fruits being the rich source of myo-inositol can be used as functional food for the treatment of polycystic ovarian syndrome.
Publication Details
Page(s) 1289-1295
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP3, Year: 2020

Request the full text from PASTIC

Keywords
Myo-inositol, Characterization, FTIR, HPLC, UV-Vis spectroscopy
References
Ashizawa N,Yoshida M,Aotsuka T,Biochem T .2000 .An enzymatic assay for myo-inositol in tissue samples. , 44(1-2) : 89-94.
Bevilacqua A,Dragotto J,Giuliani A,Bizzarri M .2019 .Myo-inositol and D‐chiro‐inositol (40: 1) reverse histological and functional features of polycystic ovary syndrome in a mouse model. J. Cell. Physiol., 234(6) : 9387-9398.
Celentano C,Matarrelli B,Mattei PA,Pavone G,Vitacolonna E,Liberati M .2016 .Myo-inositol supplementation to prevent gestational diabetes mellitus. Curr. Diabetes Rep, 16 : 30.
Jr Clements,Darnell RS,B RS .1980 .Myo-inositol content of common foods: development of a high-myo-inositol diet. Am. J. Clin. Nutr, 33(9) : 1954-1967.
D'Anna R,Di Benedetto A,Scilipoti A,Santamaria A,Interdonato ML,Petrella E,Neri I,Pintaudi B,Corrado F,Facchinetti F F .2015 .Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: A randomized controlled trial. Obstet, 126 : 310-315.
D'Anna R,Scilipoti A,Giordano D,Caruso C,Cannata ML,Interdonato ML,Corrado F,Di Benedetto A F .2013 .Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care, 36 : 854-857.
Ferreira ES,Hulme AN,McNab H,Quye A .2004 .The natural constituents of historical textile dyes. Chem. Soc. Rev., 33(6) : 329-336.
Garzon S,Laganà AS,Monastra G .2019 .Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors. Expert Opin Drug Metab Toxicol, 15(9) : 697-703.
Genazzani AD,Prati A,Marchini F,Petrillo T,Napolitano A,Simoncini T .2019 .Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both. Gynecol. Endocrinol., 35(12) : 1088-93.
Genazzani A D .2016 .Inositol as putative integrative treatment for PCOS. Reprod Biomed Online, 33(6) : 770-780.
Giordano D,Corrado F,Santamaria A,Quattrone S,Pintaudi B,Di Benedetto A,D'Anna R A .2016 .Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: A perspective, randomized, placebo-controlled study. Menopause, 18 : 102-104.
Govindarajan C,Pitchaipillai R,Shanmugasundaram B,Thangam S,Arokiasamy J,Pillai MS .2015 .Myoinositol: A review of its use in patients with polycystic ovary syndrome. W.J. Pharm Pharm. Sci., 4(6) : 137-155.
Januszewski M,Issat T,Jakimiuk AA,Santor-Zaczynska M,Jakimiuk AJ .2019 .Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS). Ginekologia Polska, 90(1) : 7-10.
Larner J .2002 .D-chiro-inositol-its functional role in insulin action and its deficit in insulin resistance. J. Diabetes Res., 3(1) : 47-60.
Larson SR,Rutger JN,Young KA,Raboy V .2000 .Isolation and genetic mapping of a non-lethal rice (Oryza sativa L.) low phytic acid 1 mutation. , 40(5) : 1397-1405.
Mancini M,Andreassi A,Salvioni M,Pelliccione F,Mantellassi G,Banderali G .2016 .Myoinositol and D-chiro inositol in improving insulin resistance in obese male children: Preliminary data. Int. J. Endocrinol., : 1-5.
Mishra D P A,Shukla RK .2017 .Spectroscopic and chemical reactivity analysis of DMyo-Inositol using quantum chemical approach and its experimental verification. Pramana, 89(1) : 12.
Nordio M,Basciani S,Camajani E .2019 .The 40: 1 myoinositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur. Rev. Med, 1(23) : 5512-5521.
Rebecca OPS,Boyce AN,Somasundram C .2012 .Isolation and identification of myo-inositol crystals from dragon fruit (Hylocereus polyrhizus). Molecules, 17(4) : 4583-4594.
Santamaria A,Di Benedetto A,Petrella E,Pintaudi B,Corrado F,D'Anna R,Neri I,Facchinetti F,Matern-Fetal Neo M. .2016 .Myo-inositol may prevent gestational diabetes onset in overweight women: A randomized, controlled trial. , 19 : 1-4.
Santamaria A,Giordano D,Corrado F,Pintaudi B,Interdonato ML,Di Vieste G,Di Benedetto A,D'Anna R A .2012 .One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric, 15 : 490-495.
Unfer V,Carlomagno G,Dante G,Facchinetti F G .2012 .Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol. Endocrinol., 28 : 509-515.
Unfer V,Nestler JE,Kamenov ZA,Prapas N,Facchinetti F .2016 .Effects of inositol(s) in women with PCOS: a systematic review of randomized controlled trials. Int. J. Endocrinol., : 1-12.
Yamashita Y,Yamaoka M,Hasunuma T,Ashida H,Yoshida KI H .2013 .Detection of orally administered inositol stereoisomers in mouse blood plasma and their effects on translocation of glucose transporter 4 in skeletal muscle cells. J. Agric. food chem, 61(20) : 4850-4854.
Yang Zeng L,K Zeng L .2018 .Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine, 59(1) : 30-38.
Zheng X,Liu Z,Zhang Y,Lin Y,Song J,Zheng L,Lin S .2015 .Relationship between myo-inositol supplementary and gestational diabetes mellitus: A meta-analysis. Medicine, 94(42) : e1604.
0

Citations

0

Downloads

15

Views